Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

Rentschler Biopharma SE, corporate

Rentschler Biopharma SE,

22.03.2021 - 10:04:13

Rentschler Biopharma and Leukocare extend service offering with joint U.S. site

and Facebook.

About Leukocare AG

Leukocare AG, located in Martinsried/Munich, Germany and Milford, MA, USA, is a biotechnology company specialized in the field of biopharmaceutical formulation development. Operating at the interface of drug substance and drug product development, Leukocare combines sound knowledge of formulation development with bioinformatics and artificial intelligence. The formulation development approach consists of two elements: a library of up to 100 different regulatory well-established and employed excipients and a rational development approach which employs statistical software and self-learning algorithms as well as state of the art design of experiment (DoE) matrices. By utilizing the artificial intelligence elements, Leukocare is able to specifically combine excipients leading to stabilizing formulations tailored to the drug product's needs. Leukocare's superior and innovative drug product formulations can be applied to a broad range of applications: biologics & biosimilars, vaccines & viral vectors and biofunctionalized devices.

www.leukocare.com

About the Rentschler Biopharma and Leukocare alliance

Launched in 2017, the global alliance between Rentschler Biopharma SE and Leukocare AG aims at integrating formulation development strategically into every step of biopharmaceutical value chain. Working closely with the client ensures a tailored and best-in-class approach for the client's drug product. This innovative approach offers clients significant competitive advantages, enabling them to optimize time-to-market and exploit the full commercial potential of their products and markets.Contact:

Rentschler Biopharma SE Dr. Cora Kaiser Senior Director Corporate Communication Phone: +49-7392-701-874communications@rentschler-biopharma.com

Leukocare AG Rebekka Str?ver Specialist Communications & Marketing Phone: + 49-89-7801-665-14rebekka.stroever@leukocare.com

Media inquiries:

MC Services AG Eva Bauer Phone: +49-89-210228-0rentschler@mc-services.euU.S. Laurie Doyle Phone: +1-339-832-0752

22.03.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

1176989??22.03.2021?

@ dgap.de